NYSE · Healthcare · Medical - Diagnostics & Research
Price at previous close. Open the live page for real-time data.
| Market cap | $174.42B |
| P/E ratio | 25.454800991398162 |
| P/B ratio | 3.361464767038891 |
| P/S ratio | 3.859030469721442 |
| Dividend yield | 0.38% |
| Return on equity | — |
| Net margin | 15.2% |
| EPS (TTM) | — |
| Beta | 0.874 |
| 52-week range | $385.46 – $643.99 |
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, a…
What is Thermo Fisher Scientific Inc.'s P/E ratio?
Thermo Fisher Scientific Inc.'s trailing price-to-earnings (P/E) ratio is 25.5.
Does Thermo Fisher Scientific Inc. pay a dividend?
Yes — the trailing dividend yield is approximately 0.38%.
What is TMO's market capitalisation?
Thermo Fisher Scientific Inc.'s market cap is approximately $174.42B.
Educational data only — not financial advice. Figures from Financial Modeling Prep, updated periodically. Verify before acting.